Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660

Article  PubMed  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA Cancer J Clin 71:7–33. https://doi.org/10.3322/caac.21654

Article  PubMed  Google Scholar 

Sun A, Durocher-Allen LD, Ellis PM et al (2019) Initial management of small-cell lung cancer (limited- and extensive-stage) and the role of thoracic radiotherapy and first-line chemotherapy: a systematic review. Curr Oncol 26:e372–e384. https://doi.org/10.3747/co.26.4481

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang S, Huang L, Zhen H et al (2021) Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis. BMC Cancer 21:1308. https://doi.org/10.1186/s12885-021-09034-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rossi A, Di Maio M, Chiodini P et al (2012) Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol 30:1692–1698. https://doi.org/10.1200/JCO.2011.40.4905

Article  CAS  PubMed  Google Scholar 

Käsmann L, Eze C, Taugner J et al (2020) Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy. Radiat Oncol 15:167. https://doi.org/10.1186/s13014-020-01595-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Denduluri N, Patt DA, Wang Y et al (2015) Dose delays, dose reductions, and relative dose intensity in patients with cancer who received adjuvant or neoadjuvant chemotherapy in community oncology practices. J Natl Compr Cancer Netw 13:1383–1393. https://doi.org/10.6004/jnccn.2015.0166

Article  CAS  Google Scholar 

Weycker D, Hatfield M, Grossman A et al (2019) Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice. BMC Cancer 19:151. https://doi.org/10.1186/s12885-019-5354-5

Article  PubMed  PubMed Central  Google Scholar 

Lim D, Kim HK, Jeong J-H et al (2020) Lipocalin2 induced by bacterial flagellin protects mice against cyclophosphamide mediated neutropenic sepsis. Microorganisms 8:646. https://doi.org/10.3390/microorganisms8050646

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shitara K, Matsuo K, Takahari D et al (2009) Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX. Eur J Cancer 45:1757–1763. https://doi.org/10.1016/j.ejca.2009.01.019

Article  CAS  PubMed  Google Scholar 

Rocconi RP, Matthews KS, Kemper MK et al (2008) Chemotherapy-related myelosuppression as a marker of survival in epithelial ovarian cancer patients. Gynecol Oncol 108:336–341. https://doi.org/10.1016/j.ygyno.2007.10.012

Article  CAS  PubMed  Google Scholar 

Yamanaka T, Matsumoto S, Teramukai S et al (2007) Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma. Br J Cancer 97:37–42. https://doi.org/10.1038/sj.bjc.6603831

Article  CAS  PubMed  PubMed Central  Google Scholar 

Banerji U, Ashley S, Coward J et al (2006) The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer. Lung Cancer 54:371–377. https://doi.org/10.1016/j.lungcan.2006.08.001

Article  PubMed  Google Scholar 

Yashiki C, Hirose T, Sugiyama T et al (2010) Chemotherapy-induced myelosuppression and treatment efficacy in limited-stage disease small cell lung cancer. Gan To Kagaku Ryoho 37:245–249

PubMed  Google Scholar 

Zhu K, Jiang M, Xu Y et al (2021) Curative efficacy might be an early predictor of prognosis in patients with small cell lung cancer treated with 2 cycles of platinum-based first-line chemotherapy. J Thorac Dis 13:1205–1214. https://doi.org/10.21037/jtd-21-216

Article  PubMed  PubMed Central  Google Scholar 

Ganti AKP, Loo BW, Bassetti M et al (2021) Small cell lung cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 19:1441–1464. https://doi.org/10.6004/jnccn.2021.0058

Article  CAS  Google Scholar 

Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207–214. https://doi.org/10.1002/1097-0142(19810101)47:1%3c207::aid-cncr2820470134%3e3.0.co;2-6

Article  CAS  PubMed  Google Scholar 

Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247. https://doi.org/10.1016/j.ejca.2008.10.026

Article  CAS  PubMed  Google Scholar 

Blazek K, van Zwieten A, Saglimbene V, Teixeira-Pinto A (2021) A practical guide to multiple imputation of missing data in nephrology. Kidney Int 99:68–74. https://doi.org/10.1016/j.kint.2020.07.035

Article  PubMed  Google Scholar 

Liu X, Zhang W, Yin W et al (2017) The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy. Medicine (Baltimore) 96:e8258. https://doi.org/10.1097/MD.0000000000008258

Article  CAS  PubMed  Google Scholar 

Steyerberg EW, Vickers AJ, Cook NR et al (2010) Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21:128–138. https://doi.org/10.1097/EDE.0b013e3181c30fb2

Article  PubMed  PubMed Central  Google Scholar 

Minami S, Ogata Y, Ihara S et al (2016) Retrospective analysis of outcomes and prognostic factors of chemotherapy for small-cell lung cancer. Lung Cancer (Auckl) 7:35–44. https://doi.org/10.2147/LCTT.S100184

Article  PubMed  Google Scholar 

Moser SS, Bar J, Kan I et al (2021) Real world analysis of small cell lung cancer patients: prognostic factors and treatment outcomes. Curr Oncol 28:317–331. https://doi.org/10.3390/curroncol28010036

Article  PubMed  PubMed Central  Google Scholar 

Johnstone TC, Suntharalingam K, Lippard SJ (2016) The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs. Chem Rev 116:3436–3486. https://doi.org/10.1021/acs.chemrev.5b00597

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amable L (2016) Cisplatin resistance and opportunities for precision medicine. Pharmacol Res 106:27–36. https://doi.org/10.1016/j.phrs.2016.01.001

Article  CAS  PubMed  Google Scholar 

Montecucco A, Zanetta F, Biamonti G (2015) Molecular mechanisms of etoposide. EXCLI J 14:95–108. https://doi.org/10.17179/excli2015-561

Article  PubMed  PubMed Central  Google Scholar 

Oun R, Moussa YE, Wheate NJ (2018) The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton Trans 47:6645–6653. https://doi.org/10.1039/c8dt00838h

Article  CAS  PubMed  Google Scholar 

Jiang C, Hu X, Wang L et al (2015) Excessive proliferation and impaired function of primitive hematopoietic cells in bone marrow due to senescence post chemotherapy in a T cell acute lymphoblastic leukemia model. J Transl Med 13:234. https://doi.org/10.1186/s12967-015-0543-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han J, Xia J, Zhang L et al (2019) Studies of the effects and mechanisms of ginsenoside Re and Rk3 on myelosuppression induced by cyclophosphamide. J Ginseng Res 43:618–624. https://doi.org/10.1016/j.jgr.2018.07.009

Article  PubMed  Google Scholar 

Săftescu S, Popovici D, Oprean C et al (2020) Endurance of erythrocyte series in chemotherapy. Exp Ther Med 20:214. https://doi.org/10.3892/etm.2020.9344

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hande KR (1992) Etoposide pharmacology. Semin Oncol 19:3–9

CAS  PubMed  Google Scholar 

Donahue A, McCune JS, Faucette S et al (2001) Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing. Cancer Chemother Pharmacol 47:373–379. https://doi.org/10.1007/s002800000260

Article  CAS  PubMed  Google Scholar 

Wang L-Y, Cui J-J, Liu J-Y et al (2018) Gene-gene and gene-environment interaction data for platinum-based chemotherapy in non-small cell lung cancer. Sci Data 5:180284. https://doi.org/10.1038/sdata.2018.284

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Yin J-Y, Li X-P et al (2014) The association of transporter genes polymorphisms and lung cancer chemotherapy response. PLoS ONE 9:e91967. https://doi.org/10.1371/journal.pone.0091967

Article